Macrophages and therapeutic resistance in cancer.

Macrophages and therapeutic resistance in cancer.
复制标题

DOI:
10.1016/j.ccell.2015.02.015
复制
发表时间:
2015-04-13
期刊:
影响因子:
50.3
通讯作者:
Coussens LM
Coussens LM
中科院分区:
医学1区
文献类型:
--
作者:
Ruffell B;Coussens LM

文献摘要

参考文献

被引文献

相似文献

肿瘤细胞对治疗的反应不仅取决于它们所包含的基因组异常的复杂性,而且还受到肿瘤微环境的许多动态特性的调节。识别和靶向通过增强抗肿瘤免疫反应来提高治疗效果的关键途径在改善预后和影响患者长期生存方面具有巨大的潜力。巨噬细胞是动态平衡组织和肿瘤微环境的关键调节细胞;因此,影响巨噬细胞存在和/或生物活性的治疗方法在临床前模型中显示出希望,目前正在进行临床评估。这篇综述讨论了迄今为止发现的巨噬细胞介导治疗反应的分子/细胞通路。
How neoplastic cells respond to therapy is not solely dependent on the complexity of genomic aberrations they harbor, but is also regulated by numerous dynamic properties of the tumor microenvironment. Identifying and targeting critical pathways that improve therapeutic efficacy by bolstering anti-tumor immune responses holds great potential for improving outcomes and impacting long-term patient survival. Macrophages are key regulators of homeostatic tissue and tumor microenvironments; thus therapeutics impacting macrophage presence and/or bioactivity have shown promise in preclinical models, and are now being evaluated in the clinic. This review discusses the molecular/cellular pathways thus far identified whereby macrophages mediate therapeutic responses.
DOI: 10.1016/j.drup.2012.01.006
发表时间: 2012-02
影响因子: 24.3
作者:
Correia, Ana Luisa;Bissell, Mina J.
通讯作者: Bissell, Mina J.
DOI: 10.1038/ni.2967
发表时间: 2014-10
期刊: Nature immunology
影响因子: 30.5
作者:
通讯作者: --
DOI: 10.1056/nejmoa1106469
发表时间: 2011-09-22
影响因子: 158.5
作者:
Corren, Jonathan;Lemanske, Robert F., Jr.;Matthews, John G.
通讯作者: Matthews, John G.
DOI: 10.1038/mt.2013.219
发表时间: 2014-01-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Devaud, Christel;Westwood, Jennifer A.;Kershaw, Michael H.
通讯作者: Kershaw, Michael H.
DOI: 10.1056/nejmoa1314768
发表时间: 2014-07-10
影响因子: 158.5
作者:
Beck, Lisa A.;Thaci, Diamant;Radin, Allen R.
通讯作者: Radin, Allen R.